BB Biotech AG

BB Biotech AG

BBAGF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.02B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BB Biotech AGBB Biotech AG2.84.17%33%25.4-
$4.34

Current Fair Value

94.3% downside

Overvalued by 94.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.02 Billion
Enterprise Value$4.85 Billion
Annual dividend$2.78
Dividend yield4.17%
Earnings per Share$10.56
Beta0.62
Outstanding Shares65,975,047

Return

Return on Equity33.03%ROE
Return on Assets32.64%
Return on Invested Capital32.65%

Valuation & Multiples

P/E Ratio2.77P/E Ratio
PEG-4.55PEG
Price to Sales25.35Price to Sales
Price to Book Ratio1.55Price to Book Ratio
Enterprise Value to Revenue22.1
Enterprise Value to EBIT4.51
Enterprise Value to Net Income4
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 23, 2026
EPS
$3.72
Reported
Revenue
$110.38 M
Reported

Next Earnings Call

Expected Date
January 22, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About BB Biotech AG

10 employees
CEO: Daniel Koller

BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of ...

Questions & Answers